UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006161 |
|---|---|
| Receipt number | R000007283 |
| Scientific Title | Phase II study of combination chemotherapy of gemcitabine, TS-1 and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer. |
| Date of disclosure of the study information | 2011/08/12 |
| Last modified on | 2022/08/20 11:01:32 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/08/12 17:44:04 | ||
| 2 | Update | 2011/08/12 17:53:20 | Last name of contact person Last name of contact person |
|
| 3 | Update | 2011/08/12 21:34:54 | Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2021/02/17 09:31:20 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2022/08/20 11:01:32 | Recruitment status Last follow-up date |
